Clarus Wealth Advisors Ionis Pharmaceuticals Inc Transaction History

Clarus Wealth Advisors

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Oct 11, 2019	SELL	$59.06 - $72.15 $129,932 - $158,730	-2,200 Closed	0 $0
Q1 2019 Apr 04, 2019	SELL	$52.92 - $81.17 $52,920 - $81,170	-1,000 Reduced 31.25%	2,200 $179,000
Q4 2018 Feb 05, 2019	SELL	$43.37 - $59.54 $17,348 - $23,816	-400 Reduced 11.11%	3,200 $173,000
Q4 2018 Jan 08, 2019	BUY	$43.37 - $59.54 $156,132 - $214,344	3,600 New	3,600 $186,000
Q4 2018 Jan 07, 2019	SELL	$43.37 - $59.54 $156,132 - $214,344	-3,600 Closed	0 $0
Q3 2018 Oct 03, 2018	BUY	$42.88 - $53.7 $102,912 - $128,880	2,400 Added 200.0%	3,600 $186,000
Q2 2018 Jul 05, 2018	BUY	$40.53 - $50.7 $48,636 - $60,840	1,200 New	1,200 $53,000

389

125M

2.25M

510K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.64B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of Clarus Wealth Advisors, based on Form 13F filings with the SEC.

Stay updated on Clarus Wealth Advisors with notifications on news.